@ARTICLE{
author={Smolen Josef S,Emery Paul,Rigby William,Tanaka Yoshiya,Ignacio Vargas Juan,Damjanov Nemanja S,Jain Manish,Kato K,Carter K,Khan N,Camp Heidi S,Cohen Stanley B},
year={2023},
title={Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate: Results at 260 Weeks from the Select-Monotherapy Study},
journal={ANNALS OF THE RHEUMATIC DISEASES},
volume={82},
number={},
pages={723-724},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Smolen Josef S,Emery Paul,Rigby William,Tanaka Yoshiya,Ignacio Vargas Juan,Damjanov Nemanja S,Jain Manish,Sui Yunxia,Enejosa Jeffrey,Pangan Aileen L,Camp Heidi S,Cohen Stanley B},
year={2019},
title={Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis: Results at 48 Weeks},
journal={ARTHRITIS & RHEUMATOLOGY},
volume={71},
number={},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Strand Vibeke,Damjanov Nemanja S,Scoville Craig,Tundia Namita,Camp Heidi S,Chen Kun,Suboticki Jessica L,Van Vollenhoven Ronald},
year={2019},
title={The Association Between Patient Reported Outcomes and Clinical Measures Among Rheumatoid Arthritis Patients: Analyses Using Phase 3 Clinical Trials of Upadacitinib},
journal={JCR-JOURNAL OF CLINICAL RHEUMATOLOGY},
volume={25},
number={},
pages={S54-S54},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Smolen Josef S,Emery Paul,Rigby William,Tanaka Yoshiya,Ignacio Vargas Juan,Damjanov Nemanja S,Jain Manish,Tanaka Yoshiya,Enejosa Jeffrey,Pangan Aileen L,Camp Heidi S,Cohen Stanley B},
year={2019},
title={Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis: Results at 48 Weeks from the Select-Monotherapy Study},
journal={ANNALS OF THE RHEUMATIC DISEASES},
volume={78},
number={},
pages={371-372},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Smolen Josef S,Pangan Aileen L,Emery Paul,Rigby William,Tanaka Yoshiya,Vargas Juan Ignacio,Zhang Ying,Damjanov Nemanja S,Friedman Alan,Othman Ahmed A,Camp Heidi S,Cohen Stanley B},
year={2019},
title={Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study},
journal={LANCET},
volume={393},
number={10188},
pages={2303-2311},
document_type={Article},
} 

@ARTICLE{
author={Strand Vibeke,Damjanov Nemanja S,Scoville Craig,Tundia Namita,Camp Heidi S,Chen Kun,Suboticki Jessica L,Van Vollenhoven Ronald},
year={2018},
title={The Association between Patient Reported Outcomes and Clinical Measures Among Rheumatoid Arthritis Patients: Analyses Using Phase 3 Clinical Trials of Upadacitinib},
journal={ARTHRITIS & RHEUMATOLOGY},
volume={70},
number={},
pages={-},
document_type={Meeting Abstract},
}